| :: 2006 :: |
The API and formulations manufacturing facilities located at Indrad (Gujarat, India) got US FDA approval
----------
Entered into an in-licensing deal with Tasly of China to market its Cardiotonic pill in India
----------
Torrent Pharma Japan Co., Ltd. incorporated in Japan. |
| :: 2005 :: |
Torrent Australasia Pty Ltd. incorporated in Australia.
----------
New manufacturing unit at Baddi, Himachal Pradesh, set up to cater to domestic formulations market.
----------
Torrent Pharma signed an agreement with Novo Nordisk India to establish a new, dedicated formulation and packaging facility for Insulin, exclusively for Novo Nordisk.
----------
Acquired Heumann Pharma GmbH & Co Generica KG, a Pfizer group company, in Germany.
----------
Two new marketing divisions- AXON and NEURON
set up to cater to neuropsychiatry segment.
----------
Entered into a research collaboration with AstraZeneca for developing novel anti-hypertensive drug. |
| ::
2004 :: |
Torrent Pharma Philippines Inc. set up.
----------
Torrent Pharma’s manufacturing facility at Indrad received MHRA (UK) and TGA (Australia) approvals.
----------
Restructuring of marketing divisions
and
addition of new division, Delta. |
| ::
2003 :: |
Brazilian Sanitary Surveillance Agency accredited Torrent’s R&D Centre with ANVISA, authorizing it to conduct Bioequivalance Studies.
----------
IDMA Quality Excellence Award Gold Trophy
for its formulations and API facilities.
----------
Torrent Pharma Inc. set up in USA.
----------
GMP Certification received from European Union by Torrent Pharmaceuticals Manufacturing Plant.
----------
MCC South Africa approval received by
Torrent Pharmaceuticals manufacturing plant. |
| ::
2002 :: |
Acquisition of a small Brazilian company, renamed
"Torrent do Brasil Ltda."
----------
Discovered and patented AGE
(Advanced Glycosylation End-products) molecule.
----------
Torrent Pharma’s manufacturing facilities
certified with ISO 14001:1996.
----------
Torrent Pharma’s manufacturing facilities
accredited with OHSAS 18001:1999.
----------
Torrent’s R&D Centre received ISO/IEC 17025:1999 for its facilities by National Accreditation Board for Testing and Calibration Laboratories (NABL).
----------
Addition of a new marketing division, MIND. |
| ::
2001 :: |
Torrent Pharma’s manufacturing facilities received
ISO 9001:2000 Certificate.
----------
IDMA Quality Excellence Award Gold Trophy
for its formulation facility.
----------
Torrent Pharma ranked in the top 10 Indian Companies in terms of Return on Capital Employed
(ET - BCG Study Feb - 2001). |
| ::
1999 :: |
| Restructuring of Torrent Pharmaceuticals Ltd. through formation of three new divisions – Prima, Vista, Psycan. |
| ::
1998 :: |
| Torrent Exports renamed as Torrent Ltd. as part of restructuring and consolidation exercise. |
| ::
1997 :: |
India Infusions Ltd. merged with
Torrent Pharmaceuticals Limited. |
| ::
1996 :: |
State-of-the-art R&D Centre commissioned.
----------
Torrent Pharmaceuticals Limited acquires pharma related investments and business of Torrent Exports Limited. |
| ::
1995 :: |
| Torrent Gujarat Biotech Limited plant commissioned. |
| ::
1989 :: |
Second manufacturing plant of
Torrent
Pharmaceuticals Limited at Chhatral. |
| ::
1983 :: |
| First Export Order |
| ::
1980 :: |
First major manufacturing facility of
Torrent Pharmaceuticals Limited at Vatva. |
| ::
1971 :: |
Trinity Laboratories renamed as
Torrent Pharmaceuticals Limited. |
| ::
1959 :: |
| Mr. U.N.Mehta started pharma operations. |
